Oklo Clears Regulatory Hurdle for First Commercial Nuclear Reactor. The Stock Rises. -- Barrons.com

Dow Jones06-11

By Mackenzie Tatananni

Pre-revenue nuclear start-up Oklo has taken another step toward commercializing its technology, clearing a key regulatory hurdle for its upcoming Aurora powerhouse at Idaho National Laboratory.

The stock rose 5.4% in premarket trading Thursday to $56.92.

The Energy Department approval relates to Aurora's preliminary documented safety analysis, a review of the reactor's safety controls, design, and hazard management. CEO Jacob DeWitte described the clearance as an "important milestone" and a foundation for future deployments.

Oklo is one of nearly a dozen companies selected for a federal pilot program in 2025. The initiative is on a tight schedule, aiming to have at least three test reactors running at U.S. national laboratories by the start of next month.

Earlier this week, the Energy Department confirmed that a design from rival Antares Nuclear will be the first of several reactors to go critical by the July 4 deadline.

Aurora is the first of Oklo's planned powerhouses. It will run on recovered fuel from the Experimental Breeder Reactor-II, which was shut down in 1994 following a government policy pivot and subsequent congressional defunding.

Oklo is building its own fuel fabrication site on the grounds of Idaho National Laboratory. The start-up is exploring ways to use plutonium as a temporary "bridge fuel" while the U.S. builds out domestic supply chains for traditional fuels like high-assay low-enriched uranium.

Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

June 11, 2026 08:11 ET (12:11 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment